Implementation of Team Clinic for Type 2 Diabetes (TCT2)
Implementation of Team Clinic for Type 2 Diabetes (TCT2): A Randomized Standard Care-controlled Two-site 80-subject Clinical Trial of Shared Medical Appointment Model for Adolescents With Type 2 Diabetes
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 12 Years to 18 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Participants will attend quarterly clinic appointments and group activities and take surveys."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
The goal of this clinical trial is to learn if shared medical appointment is an acceptable way to deliver care to youth with type 2 diabetes. The main question\[s\] it aims to answer are: * Is shared medical appointments an acceptable care delivery model for this population? * Does shared medical appointment improve psychosocial outcomes for this population? Participants will attend quarterly clinic appointments and group activities and take surveys. Researchers will compare this intervention to standard of care.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Patient/AYA Participants Inclusion Criteria: * Receives care for type 2 diabetes at either CHLA or UCSF * English speaking youth * Youth prescribed medication for type 2 diabetes * English or Spanish speaking caregivers * Age 12 to 18 years old at the time of enrollment * Willingness to attend clinic visits and participate in group session (if randomized to Team Clinic), complete surveys Exclusion Criteria: * Participants who are non-verbal or unable to participate in group activities and discussions * Pregnancy * Inability or unwillingness of individual or legal guardian/representative to give written informed assent/consent Caregiver/Parents Participants Inclusion Criteria: * Has a child between the ages of 12 and up to 18 at the time of enrollment who receives care for T2D in the endocrinology clinic at CHLA. The child must provide consent/assent to participate as a youth participant. * Speaks English of Spanish. Over 95% of our T2D population speaks one of those two languages. Our facilitator will be bilingual in English and Spanish. It is not feasible for the facilitator to also speak another language. Having a language interpreter for discussion groups will affect the dynamics and flow of the group session * Willingness to participate in group session (if their child is randomized to Team Clinic) and complete surveys. Exclusion Criteria: -Inability or unwillingness of individual to give written informed consent
Study sites (2)
CA
- Children's Hospital Los Angeles · Los Angeles, CA 91316Lily Chao, MD, MS · Principal investigatorMore trials in Los Angeles
- University of California, San Francisco · San Francisco, CA 94143-0434More trials in San Francisco